Teva Pharmaceutical Industries has unveiled Rise, its first global innovation platform, inviting startups to propose breakthrough solutions to seven major challenges spanning manufacturing, clinical development, commercialization and patient experience. The program aims to accelerate new technologies that improve patient outcomes and strengthen operational efficiency, aligning with Teva’s “Pivot to Growth” strategy to position the company as a leading biopharma player.
Teva expects more than 100 applications and plans to select pilot companies in March, depending on the strength of submissions.
Read full article here: turnovernews.com
Read also: Norofert officially opens its new production facility in Brazil
Photo: CTech
UK
IT
ES
DE
FR
RO
PT
HU
